• Through its “Growth as a Service” offering, XESP is making technology implementation easier and more effective
• Its Digital Engagement Engine(TM) allows it to achieve greater reach and lift, affording companies the ability to maintain control of their content while creating meaningful relationships with new customers and revenue streams
• This technology’s potential has seen XESP tap into growth in the conversational commerce market, offering meaningful conversations to end users through a combination of automation and cutting-edge data analysis, facilitating business growth and driving up engagement

Electronic Servitor Publication Network (OTC: XESP), a market disruptor for B2B companies using advanced data analysis and smart technology, is driving up a unique value proposition to improve client outcomes. The company’s understanding of technology, its potential and its current role in facilitating positive customer relationships and influencing business growth has earned it a significant competitive edge over its peers. The company is targeting a bigger share of the global customer engagement solutions market, set to be valued at $32.2 billion by 2027 (https://ibn.fm/GJ4bK).

Recently, there has been a massive uptake of technology, specifically artificial intelligence (“AI”), in business circles. In 2022, the global AI market was valued at $136.55 billion, estimated to grow to $1.81 trillion by 2030. This expected growth is primarily attributed to the mounting investments in AI technologies, its competitive advantage, and the potential digital disruption it represents. For further context, AI is expected to contribute to the world economy over the current output of both India and China combined by 2030 (https://ibn.fm/2JNID).

XESP understands the current direction, and through its offering, it is advancing the technologies and helping businesses harness their potential and realize their goals in the process. Through its “Growth as a Service” offering, the company is making technology implementation borderline effortless, allowing business owners to focus on their brands, core product offerings and content creation while it manages the technology and outcome.

Of note is its Digital Engagement Engine(TM), which leverages a combination of automation, unique data management, and a modern workflow founded on microservices architecture. This technology provides XESP clients with greater reach and lift for and complete control of their content. The technology also provisions data that allows clients to learn and predict audience interests and trends.

With XESP’s Digital Engagement Engine (TM), businesses can offer their customers personalized connections that result in higher conversions and a better customer experience. They can also keep their data current with little to no intervention, which is often linked to higher customer retention and higher customer satisfaction. With 75% of business owners noting that AI will play an important role in the future of their brands, XESP has positioned itself strategically in the market, and its Digital Engagement Engine(TM) is well-placed to offer value for its existing and potential clientele.

The potential of XESP’s Digital Engagement Engine(TM) has seen it tap into the growth of conversational commerce, which has proven to be the future of marketing. The company can offer meaningful conversations to end users through automation and cutting-edge data analysis, unique data management, and a modern workflow, ultimately facilitating business growth and driving up engagement.

“The Digital Engagement Engine overlays with the [conversational marketing and omnichannel content publication] tool to ensure that you are having a co-created conversation that is meaningful to the individual user rather than a one-size-fits-all,” noted Peter Hager, XESP’s CEO. “That meaningful interaction drives a greater relationship with your audience and trust. Ultimately, it drives greater growth in your organization and, very simply put, replicates what you do face-to-face. And if we can do that online, which the Digital Engagement Engine helps you do, you’re going to produce better results,” he added (https://ibn.fm/enLnL).

XESP understands the value of its offering. In addition, it is cognizant of companies’ increasing awareness of the trends in AI and conversational marketing. As such, the company seeks to take over the market and assert itself as the undisputed market leader through its unique market positioning and offering. Its management has expressed confidence in its trajectory while sharing its optimism about where the company is headed. This reflects its commitment to improving client outcomes and creating shareholder value.

For more information, visit the company’s website at www.XESPN.com.

NOTE TO INVESTORS: The latest news and updates relating to XESP are available in the company’s newsroom at https://ibn.fm/XESP

• Lexaria’s NIC-H22-1 study proved that its patented DehydraTECH(TM)-nicotine tobacco-free pouch was statistically significantly faster-acting than alternatives
• The study, which involved 36 participants, embraced a randomized, double-blind, cross-over study design
• It also affirmed Lexaria’s product superiority while also showing DehydraTECH’s potential

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released results from its 2023 human oral nicotine study NIC-H22-1. Of note was its patented DehydraTECH(TM)–nicotine tobacco-free pouch product superiority, particularly when pitted against world-leading brands ZYN(R) and on!(R). The study proved that Lexaria’s product was statistically significantly faster than the two alternatives in the median time required to reach comparable maximum nicotine concentrations (“Tmax”) levels (https://ibn.fm/aV8AU).

Lexaria’s CEO, Chris Bunka, lauded his team for this achievement, especially considering they had to work without as many resources as global multi-billion-dollar behemoths. He also lauded the company’s technology, citing its potential and advantages, as demonstrated in the study.

“This is a remarkable achievement that speaks to the capabilities of the DehydraTECH technology and also to the Lexaria R&D team, working ardently with scarce resources relative to global multi-billion-dollar behemoths,” he noted (https://ibn.fm/aV8AU).

Several intriguing data trends were observed from the study. For one, most of the subjects reported that they felt euphoric at all time points when they used Lexaria’s product. Lexaria also got the highest endorsement score, with statistical significance demonstrated at the second dosing visit. The highest percentage of users reporting that they considered the experience “pleasurable” at the 30-minute mark were also Lexaria users, and the company also scored best on the enjoyment scale.

Negative effects, meanwhile, such as nausea and severe hiccups were experienced more by the mass-market products than by the Lexaria formulation.

The study embraced a randomized, double-blind, cross-over study design involving 36 participants, all long-time heavy cigarette smokers who smoke at least ten cigarettes a day. Subjective effects, both positive and adverse, were assessed at baseline, 5 minutes, 30 minutes, and 120 minutes using a questionnaire to capture 25 different effects. All laboratory procedures for the study were conducted entirely by U.S.—based, third-party independent contract service providers (https://ibn.fm/aV8AU).

The results from this study not only validate Lexaria’s efforts but also affirm its product superiority while also showing DehydraTECH’s potential. This is a tremendous achievement for the company, given that this has been achieved in just five years. It reflects the company’s commitment to making the world a better place and its resolve to create value for its shareholders.

“We’ve always had an overwhelming determination and fierce conviction that we can make the world a better place and reduce the carnage caused by smoked cigarettes, and now we have human study data that demonstrates the advantages of DehydraTECH processed nicotine relative to the competitive landscape,” noted Mr. Bunka (https://ibn.fm/aV8AU).

For company information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Electronic Servitor Publication Network is a technology-oriented digital engagement and activation company
• The company has developed and is commercializing its Digital Engagement Engine(TM), which helps companies elevate digital content and drive better digital interactions within current and new communities
• Customer experience experts agree that companies need to embrace technologies to maximize customer satisfaction and methodically cultivate superior end-to-end CX capabilities
• Using its sophisticated technology stack, employed as a managed service, XESP helps companies build end-to-end capabilities that allow them to win and maintain customers in the present, while capturing future opportunities

Customer experience is the process of measuring, analyzing, enhancing, and delivering superior customer interactions with a brand or business (https://ibn.fm/LC8zk). As such, companies need to pay attention to the full customer experience (“CX”) in order to unlock short-term profitability and also build long-term sustained advantage. This is seen as requiring a carefully crafted and orchestrated CX approach, a survey by consulting firm BCG reveals (https://ibn.fm/TjfW6).

BCG, which interrogated digital transformations at major organizations globally, established that companies leading in CX created 55% more value, recorded 190% higher revenue growth, and witnessed 70% higher customer loyalty than competitors that did not invest in CX. Furthermore, according to the survey, the CX landscape is changing, driven by data and digital transformation, increasing investments in the space, and the growing recognition of the value CX holds as a source of competitive advantage and a strategic differentiator.

With this in mind, BCG recommends business should strive to “reimagine their approach to operations, talent and technology with the customer as a starting point” and harness data, artificial intelligence (“AI”) and AI-powered automation, personalization, and other technologies to maximize customer satisfaction. Moreover, companies should “methodically cultivate end-to-end capabilities that allow them to win customers in the present and capture new opportunities in the future.”

Broadly speaking, there is a consensus of opinion around the value of CX, with experts echoing or supplementing the findings of the BCG report. On her part, Jeannie Walters, an award-winning customer experience professional, observes that business leaders can leverage automation and technology to provide excellent customer experiences while adapting to challenges caused by inflation, labor shortages and supply chain disruptions.

“Customers are looking for personalized experiences,” writes Walters in an article in CMSWire (https://ibn.fm/2FZyf). “By leveraging technology, businesses can offer personalized experiences and improve customer satisfaction rates. For instance, businesses can use chatbots to provide quick and efficient customer service, or they can use data analytics to better understand customer needs and preferences.”

The consistent message within this space is that companies need to build a robust infrastructure, use reliable technology, and develop strong processes that foster a deeper understanding of customers, improve their execution of customer interactions, and drive innovation. And this is where Electronic Servitor Publication Network (OTC: XESP), a managed service digital engagement and activation company, comes in.

A market disruptor for B2B companies using cutting-edge technology to reach their target markets, XESP has developed and is commercializing its Digital Engagement Engine(TM), which combines automation, unique data management and microservices architecture to elevate digital content and drive better digital interactions within current and new communities. The company anchored the development of the Digital Engagement Engine(TM) in data analysis and smart technology, creating a tech stack that can identify even the narrowest of niches within clients’ respective target markets, tailor content to meet their exact needs, and deliver the content to them right when they need it.

Remarkably, XESP’s approach is not lifted from the conventional CX playbook; it is rather unique. And as the company CEO Peter Hager explained in an interview with Proactive (https://ibn.fm/LppE0), this uniqueness is responsible for making the company good at what it does. “We just took an immense amount of focus on what happens when you’re not face to face with your customers. Many people look at the customer experience as a face-to-face [interaction] or just the brand, but they haven’t really followed the journey of the customer when they’re not face to face,” explained Hager.

XESP resolved to tackle the underlying problem by creating a system that allows client companies to sense and respond to what their users and customers are looking for when interacting with them digitally. This approach, according to Hager, created an edge.

By using Electronic Servitor Publication Network’s sophisticated technology, which the company employs as a managed service, client companies do not need to continually add tools, services or personnel to achieve growth through new or existing products and services. In fact, XESP’s service functions with and at a level above a company’s existing personnel, programs and infrastructure. XESP helps companies build end-to-end capabilities that allow them to win customers in the present and capture new opportunities in the future.

For more information, visit the company’s website at www.XESPN.com.

NOTE TO INVESTORS: The latest news and updates relating to XESP are available in the company’s newsroom at https://ibn.fm/XESP

• Lexaria’s human oral nicotine study, NIC-H22-1, comparing world-leading brands and the company’s DehydraTECH(TM)-Nicotine tobacco-free pouch, reported positive results, including higher pleasurable effects and reduced negative effects
• A new patent has been granted to Lexaria and is strategically important to the company’s oral nicotine sector research and development efforts
• Lexaria continues to research diabetes control and weight loss with its DehydraTECH(TM)-CBD, announcing favorable animal study results and the intent to develop a human clinical study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced updates regarding its patented DehydraTECH(TM) technology – which improves the way that active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. Lexaria’s primary focus for DehydraTECH research and development includes advancements of product candidates across key segments, including nicotine replacement, diabetes control and weight loss, and hypertension.

The company’s most recent announcement reported results from its 2023 human oral nicotine study NIC-H22-1, comparing Lexaria’s DehydraTECH(TM)-Nicotine tobacco-free pouch to world-leading brands ZYN(R) and on!. Using measurements to determine the median time required to reach comparable nicotine concentrations within the bloodstream (“Tmax”), Lexaria exhibited higher levels of certain pleasurable effects over the competition. DehydraTECH also provided the lowest frequency of unwanted negative effects, including moderate to severe nausea, demonstrating benefits from Lexaria’s formulation.

In addition to the announcement of favorable results from its NIC-H22-1 study, the company was recently granted a strategically important new patent in the oral nicotine sector by the United States Patent and Trademark Office, US Patent #11,700,875 Compositions and Methods for Sublingual Delivery of Nicotine. This new patent builds upon the company’s growing portfolio of 35 granted patents, with several more pending worldwide – spanning Lexaria’s research and development focus.

“We’ve always had an overwhelming determination and fierce conviction that we can make the world a better place and reduce the carnage caused by smoked cigarettes, and now we have human study data that demonstrates advantages of DehydraTECH processed nicotine relative to the competitive landscape,” said Chris Bunka, CEO of Lexaria (https://ibn.fm/nrgGY).

Separately, Lexaria also intends to conduct a human clinical study to examine its DehydraTECH-CBD formulation for diabetes control and weight loss. This intent comes after positive results were released in early August regarding its DIAB-A22-1 study in obese diabetic-conditioned animals, which achieved the following:

• Lowered blood glucose levels by 19.9% (p<0.05)
• Lowered overall body weight by 7% sustained over eight weeks
• Witnessed a statistically significant increase in locomotor activity (p<0.05)
• Lowered triglyceride levels by more than 25% (p<0.007)
• Lowered blood urea nitrogen levels by 27.9% (p<0.001)

These successful pre-clinical results have the company determined to undertake a human study to investigate whether these improvements are also evidenced in humans. The study design is currently underway and will be submitted to an independent review board for approval.

As the company continues to grow and explore maximizing the potential of its DehydraTECH technology, a new wholly-owned subsidiary under the name Lexaria Nutraceutical Corp. (“LEXX Nutra”) has been formed. LEXX Nutra has been granted an exclusive, perpetual license entitling it to use DehydraTECH, or sublicense the use of DehydraTECH, to create consumer packaged goods and/or intermediate ingredients composed of any molecule except those associated with cannabis or nicotine. LEXX Nutra is also prohibited from using its licensing to manufacture any pharmaceutical product.

Lexaria Pharmaceutical Corp.’s licensing was also amended, ensuring it would only focus on manufacturing pharmaceutical products–excluding nicotine-associated molecules. The formation of Lexaria’s wholly-owned subsidiaries draws a distinct line in the sand for Lexaria, ensuring that proper research and development efforts for key indications are being diverted to the appropriate subsidiary.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• The United States and other Western nations have been embroiled in trade tensions with China since 2018 as a consequence of China’s efforts to control its industries’ exports of metals critical to modern digital and green technologies
• China imposed new licensing controls on the exports of the metals gallium and germanium that it processes, prompting fresh concerns about China’s ability to choke resources to the global market it supplies
• Ucore Rare Metals is a supply chain innovator dedicated to increasing American production of critical metals in order to reduce reliance on trade with China
• Ucore’s proprietary RapidSX(TM) processing solution for select rare earth elements (“REEs”) is being developed as a means of sustaining domestic REE production for applications ranging from electric vehicle batteries to national defense weaponry

Restrictions imposed earlier this month by The People’s Republic of China on the export of two semiconductor metals represent the latest flashpoint in the years-long trade and technology war between the Asian nation and the United States and, in its development, a rationale for American production of resources critical to modern technology manufacturing.

Some Western pundits have scarlet-lettered China’s requirement that exporters of gallium and germanium get authorization through a government license before shipping those metals out of country, branding it as an unfaithful act of retaliation (https://ibn.fm/RDAOe). China, sensitive to the criticisms, has replied at length that the controls are the result of a “legitimate” effort by the country to protect its own limited resources, its position in the marketplace and its national security (https://ibn.fm/qJFCT).

Canada-based critical technology metals supply chain innovator Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is at the forefront of American attempts to shore up domestic mining and processing of metals necessary to modern technology, including some of the 15 rare earth elements (“REEs”) that are also largely controlled by China’s industry and, by extension, its government.

Ucore’s passion for building and sustaining domestic REE processing is evident in its public-facing messaging as it tests its proprietary RapidSX(TM) solvent extraction process for REEs at an Ontario demonstration plant in preparation for construction and operation of a commercial-scale separation facility in Louisiana, which contractors are slated to start building later this year.

“If you’re making a chemical concentrate, or any type of concentrate, from a rare earth mine, you have no option today other than to send it to China for processing and it will get used in Chinese processing at that time. It will get used in F-35 fighters. … That’s not right,” Ucore CEO Pat Ryan said in an interview with InvestorIntel last year (https://ibn.fm/geJAj).

“We’re working upstream with all the near-term producers that only have an option to send product back to China,” Ryan added, to convince them, “Let’s process on North American soil. Here are our plans. … Here’s our tech. Here’s our list of customers. … Let’s get the job done.”

Although silicon is the principal source of semiconductor material in modern applications, germanium and gallium have numerous high-tech applications in the rapidly evolving world of digital technologies, ranging from fiber optic cables and 5G telecommunications masts, to military-grade thermal imaging, lasers, light-emitting diodes (“LEDs”), satellite solar panels and rare-earth magnets in the engines of electric vehicles (“EVs”), a Fastmarkets report noted recently (https://ibn.fm/cVzJa).

Participants in other critical raw material markets are paying attention to China’s export controls, the article noted.

“Cobalt and nickel producer Jervois Global has spoken out against what it describes as China using its market dominance ‘to choke off key materials for advanced chips,’ ” it states, quoting the company’s social media comment that “America, with no meaningful stockpile/inadequate mining/refining, can currently do little” to abate its reliance on overseas sources of strategic and critical minerals.”

While the government has provided some companies — including Ucore — with funding to explore domestic production and processing options, the Semiconductor Industry Association has expressed concern about new restrictions on trade with China imposed by the United States’ executive office this month, asking both countries to ease tensions to avoid “diminishing the U.S. semiconductor industry’s competitiveness, disrupting supply chains, causing significant market uncertainty, and … continued escalatory retaliation by China” (https://ibn.fm/FVUZL). 

For more information, visit Ucore’s website at www.Ucore.com.

NOTE TO INVESTORS: The latest news and updates relating to UURAF are available in the company’s newsroom at https://ibn.fm/UURAF

• A report published by Allied Market Research noted that in 2019, the global challenger bank market generated $20.4 billion and should post over $471 billion in revenue by 2027
• This growth will be attributed to the reduced associated costs, accessibility and overall convenience that the challenger bank market offers
• Through its strategic acquisition approach, FEXD is advancing this sector while offering consumers the services and flexibility they need
• By doing so, FEXD hopes to reduce poverty, improve the lives of the unbanked, and offer security and saving options for migrant workers

Fintech Ecosystem Development (NASDAQ: FEXD) is, through strategic mergers and acquisitions, helping accelerate the growth of the challenger bank market. In turn, the company is making financial services affordable and accessible, particularly to individuals in emerging markets, who grossly lack this access compared to their counterparts in developed regions. This focus is helping FEXD carve out a significant market share and leave an indelible mark, even as the world gradually shifts to digital currency.

In a report published by Allied Market Research, it was noted that, in 2019, the global challenger bank market generated $20.4 billion. The report then estimated that, by 2027, this market would post over $471.0 billion in revenue, representing a CAGR of 48.1% over the forecast period (2020-2027) (https://ibn.fm/fNIyy). In addition, the cryptocurrency market size is expected to post a CAGR of 15.81% between 2022 and 2027.

Key factors that will facilitate this growth include the reduced cost associated with this solution and the level of accessibility and convenience that comes with it. In addition, changing consumer and business needs have facilitated this industry’s growth to the point of forcing legacy institutions to re-invent themselves and offer products that accommodate or address the new consumer demands.

FEXD understands this shifting course, and through its strategic approach to expansion and growth, it is offering consumers what they want while playing a role in advancing the challenger bank and crypto markets. By doing so, it is helping support developing countries, offering the people therein a chance to improve themselves financially and improve their livelihoods while at it.

“We’re committed to supporting the progress of developing countries and cultures,” notes the FEXD website.

“We have a keen understanding of market needs in many regions of the world where cellphones are in wide use, but mobile money services are not yet available,” it adds (https://ibn.fm/FBPCI).

FEXD is channeling its resources and attention into these emerging markets, hoping that by doing so, it will ensure that “humanity has a path forward from an unhygienic cash system.” The company also hopes that its efforts will reduce poverty, improve the lives of the unbanked, and offer security and saving options for migrant workers.

Back in September 2022, FEXD announced an ambitious definitive agreement for a business combination with Mobitech International LLC., where it would become a wholly owned subsidiary of FEXD. Mobitech, an artificial-intelligence-enabled digital lending platform, would help elevate FEXD’s product offering while bringing it closer to its goal of affording financial inclusion to persons in emerging markets.

These moves reflect FEXD’s commitment to achieving its short-term and long-term objectives. More so, they speak of the company’s understanding of the market, the existing market opportunity, and the current direction the challenger bank market is taking. Its management remains optimistic about the company’s future and progress, even as it eyes the financial technology market, which is expected to hit $500 billion by 2028.

For company information, visit the company’s website at www.FintechEcoSys.com

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

• Similar business model but different antibody therapies for psoriasis treatment, BiondVax uses NanoAbs while Apogee Therapeutics, Inc. uses conventional mAbs
• BiondVax NanoAbs provide superior benefits not seen in mAb therapies, including new routes of administration, higher affinity, better binding, and a higher level of stability at room temperature
• Apogee recently went public at $500 million pre-money, raising $300 million in an upsized deal, and has a $1 billion market cap – should be an eye-opener to BiondVax investors who recognize benefits of NanoAbs over mAb development
• The global psoriasis treatment market was valued at $26.13 billion in 2022 and is anticipated to reach $57.84 billion by 2031, growing at a CAGR of 9.23%

Modern-day medicine has been revolutionized and personalized to cater to more specific disease characteristics. A prime example of this innovation is monoclonal antibodies (“mAbs”) and nanosized antibodies (NanoAbs), therapeutic options that address diseases in ways other therapies cannot. Several companies are penetrating the market and a compelling comparison can be made between two – one supporting mAbs and the other NanoAbs. Both companies share similar objectives and stages of development.

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, is focused on the development of NanoAbs derived from alpacas. Alpaca-derived antibodies, also called VHH-antibodies, exhibit the potential for superior biobetter therapies that could be used for a wide range of diseases. BiondVax’s current pipeline is targeting COVID-19, psoriasis, asthma, and other diseases with large unmet medical needs – with collaboration from the prestigious Max Planck Institute for Multidisciplinary Sciences (“MPG”) and the University Medical Center Göttingen (“UMG”), both in Germany.

Apogee Therapeutics (NASDAQ: APGE), a biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications, is focused on the development of conventional mAbs therapeutics (https://ibn.fm/z8e1F). The company’s technology approach has been shown to create antibodies with significantly extended half-life and other optimized properties. The primary enhancement that Apogee hopes to achieve through its mAb development is a slightly longer duration of benefit and slightly fewer drug administrations.

Despite the benefits that conventional mAbs offer, BiondVax’s NanoAbs may offer superior benefits that Apogee’s formulations cannot, such as:

• The opportunity for new routes of administration, such as inhalation and intradermal injection – neither of which work well with traditional antibody therapies, thereby creating new market opportunities for BiondVax without competing head-to-head with existing antibody treatments
• A higher affinity and better binding to the target, permitting lower dosages, fewer side effects, and lower costs overall
• Stability at room temperature, unlike regular antibodies that need cold chain logistics until they are administered to the patient thus limiting where and when administration occurs

The potential benefits of BiondVax’s NanoAbs have been showcased in the company’s own pre-clinical studies, and the company is planning a rapid development path that leverages its expertise and capabilities in biological drug development and manufacturing.

Apogee and BiondVax are targeting the immune system’s IL-17 cytokine as they develop their drugs; IL-17 is involved in several diseases with BiondVax initially targeting IL-17 towards a psoriasis treatment.

The global psoriasis treatment market was valued at $26.13 billion in 2022 and is anticipated to reach $57.84 billion by 2031, growing at a CAGR of 9.23% (https://ibn.fm/EfBfN). The market is expected to grow at this rate due to the increased awareness of the affliction and the advancement in therapies associated with it. BiondVax’s VHH antibodies propose a different approach to treatment, which does not necessarily compete head-to-head with treatment options, but provides a unique alternative approach.

Apogee only recently went public a few weeks ago at $500 million pre-money, raising $300 million in an upsized deal, and now the company has a $1 billion market cap. BiondVax’s NanoAb advantages over Apogee’s mAbs offer an attractive prospect to investors who are looking to get in early on the “bio better” antibody movement. With huge potential and a market cap that’s currently miniscule in comparison, only about $5 million and trading under a $1.50 per share, its little wonder that Aegis Capital reiterated its buy rating with a $7 price target (https://ibn.fm/wFWBO).

For more information, visit the company’s website at www.BiondVax.com.

NOTE TO INVESTORS: The latest news and updates relating to BVXV are available in the company’s newsroom at https://ibn.fm/BVXV

• FEXD is developing a global financial technology ecosystem that will address unmet mobile money needs in developing and industrialized markets and make it easier and more affordable to transact digitally
• The company aims to use emerging technologies such as AI to reduce costs associated with and fast-track the processing of money transfers and loans
• AI is a powerful technology that has been positively associated with the improvement in digital financial inclusion
• The technology is used in credit risk assessment, investment-related decision-making, fraud detection and prevention, prediction, and customer service
• With FEXD eying digital money transfers, which are unfortunately prone to cyber threats and fraud attempts, the company aims to tap into the power of AI to promote security and efficiency, thus driving digital financial inclusion

Long before large language models (“LLMs”) like ChatGPT and Bard democratized artificial intelligence (“AI”), this powerful technology existed and was deployed in different industries. The banking, financial services, and insurance (“BFSI”) industry, for instance, is recognized as one of the earliest and most prominent adopters of the technology, having first incorporated some form of AI about three and a half decades ago (https://ibn.fm/wZMQi). But the rise of new frontiers in AI, such as generative AI, of which LLMs are part, has created new opportunities that incumbents and startups can use to their benefit.

The earliest implementation of AI in the BFSI space was in the domain of credit risk assessment. And many years on, financial services companies such as banks and lenders still use the technology to assess the creditworthiness of customers. But, compared to the formative years, AI has evolved, thanks in large part to a combination of better big data collection and storage capabilities (the data is used to train AI models), increasing computational power, and AI research. As a result, the capabilities of AI have comparably increased, birthing tools that help businesses make decisions around investments, predict trends, detect and prevent fraud and financial crime, offer more personalized customer communication, and more (https://ibn.fm/UEYv4).

On their part, fintech companies, which are also part of the BFSI industry, are looking to expand the scope of what is possible with AI, delivering new or less common ways of implementing and leveraging the technology in addition to what has traditionally been used. One such company is Fintech Ecosystem Development (NASDAQ: FEXD). Formed in 2021, FEXD aims to develop a global financial technology ecosystem. The company is keen on addressing unmet mobile money needs in developing and industrialized markets and making mobile transactions easier and more affordable. To turn its vision into a reality, FEXD is adopting emerging technologies like AI.

“We aim to use emerging technologies such as blockchain, Web 3.0, Metaverse, and artificial intelligence (‘AI’) to reduce costs and accelerate the processing of money transfers, loans, and other lifestyle services which will benefit consumers and businesses in many countries,” said Dr. Sainful Khandaker, CEO, President, and Founder of FEXD (https://ibn.fm/FJiL5).

Digital or mobile money transfers and peer-to-peer (“P2P”) platforms enhance financial inclusion by increasing the number of individuals who have access to financial services. Unfortunately, as the number of digital transactions grows, so too does the number of digital fraud attempts. According to a recent study, such attempts increased by 80% from 2019 to 2022 (https://ibn.fm/VcSdu).

Given the role AI has historically played in helping companies detect, measure, and manage risk, it is still being called upon to deal with financial crime and cyber threats and detect fraud. In addition, and alongside these crucial applications of the technology, companies are also using AI to provide information that customers would ordinarily not access using traditional routes. In this way, AI and AI-enabled solutions also promote digital financial inclusion (https://ibn.fm/XK9uB).

Moreover, the rise of generative AI also portends improvements in how companies like FEXD deliver their services and products to their customers. It is poised to enable hyper-personalization of financial products and services, help customers make financial decisions much faster (hence accelerate money transfers), and facilitate digital financial concierges, which, according to consulting firm BCG, will help customers automatically complete tasks such as sending remittances, disputing charges, paying bills, and more without requiring their input (https://ibn.fm/HCt5d).

FEXD aims to tap into these capabilities of AI to power its financial systems, driving digital financial inclusion. By harnessing the power of AI, which has been proven to detect and manage risks associated with fraud, cyber threats, and financial crimes, FEXD hopes to process money transfers and loans both securely and more efficiently than ever before. Moreover, should customers require any help, the company expects to deploy generative AI solutions.

To actualize its goals, the company intends to merge with or acquire high-growth global fintech targets primarily operating in South Asia. The targets include fintech service providers that will benefit – or are benefiting – from incorporating more advanced technologies, chief among them AI-enabled solutions. One of its acquisition targets, Mobitech International LLC (dba Afinoz), is a digital lending platform and fintech marketplace in India that uses AI-powered tools to make complex personal money decisions simple and transparent. The company uses these tools to provide its customers with unbiased advice and help them choose the most suitable financial products and access and compare multiple personal credit offers.

For more information, visit the company’s website at www.FintechEcoSys.com.

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

GolfLync, the premier social media platform for golf enthusiasts, is proud to announce a significant milestone, surpassing 50,000 members across the United States. The exponential growth is a testament to the platform’s ability to bring golfers together, fostering vibrant golfing communities and connections that continue to flourish.

From local golf clubs to nationwide networks, GolfLync’s Virtual Golf Clubs(TM) (“VGC”) have transformed the way golfers connect, share, and experience the game they love. Members are embracing the platform’s innovative features, with private and public VGCs serving as hubs for planning tee times, sharing insights, and building lasting golfing friendships.

The viral scale of GolfLync’s growth can be attributed to the genuine enthusiasm and engagement of its members. Tens of thousands of posts, photos, videos, and tee times have been shared, turning GolfLync into a dynamic hub of golfing activity. The ability to have dedicated posts, chats, and feeds for individual clubs adds an extra layer of personalization, allowing members to tailor their experiences to their golfing passions.

Mike Quiel, Co-Founder of GolfLync, expressed his excitement about the platform’s success: “Listening to our users and shaping our features around their needs has been the driving force behind GolfLync’s remarkable journey. We are thrilled to see our vision come to life as golfers from all corners of the country come together to create thriving golfing communities.”

GolfLync’s success mirrors the strategies employed by other social media giants like Facebook and Instagram (NASDAQ: META), Pinterest (NYSE: PINS), and top social APPs such as Match (NASDAQ: MTCH), Hello Group (NASDAQ: MOMO), and SnapChat (NYSE: SNAP), who all realized that building user engagement around communities was the key to explosive growth.

As GolfLync’s membership continues to rise and its golfing communities flourish, the platform remains committed to fostering connections, enhancing experiences, and providing golf enthusiasts with a space to connect, share, and celebrate their shared passion.

For more information about GolfLync and its cutting-edge offerings, visit the official website at www.GolfLync.com and experience golfing like never before.

GolfLync APPs are available for free from both the Apple Store GolfLync and Google Play GolfLync – Apps on Google Play.

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

Financial analysts, business owners, investors, financial institutions, and regulators, are invited to attend FinovateFall, held in the Marriott Marquis Times Square, New York City, September 11-13, 2023. The much-awaited event is returning to bustling New York City. Featuring interactive sessions, live demos, and unlimited entertainment options, FinovateFall promises to be a fintech extravaganza that sparks innovation and creativity.

Important thought leaders will share their perspectives on the future of finance through engaging seminars and live demos showing the latest in fintech developments, all while offering off-hours NYC entertainment opportunities that will keep participants captivated. New York’s unmatched nightlife never fails to impress with enthralling live performances by brilliant musicians, ranging from grand concert halls to intimate jazz bars, along with top Broadway shows, great restaurants, comedy club entertainment, and a bevy of informal tourist attractions.

A Remarkable Experience Buzzing With Creativity

FinovateFall is a mix of valuable new financial opportunities and fun-filled surprises. Fintech leaders and enthusiasts will take the stage to showcase their latest products and solutions, while engaging case studies will provide in-depth information about new technologies and how revolutionary ideas will change the fintech landscape. Attendees will experience an immersive environment that ignites a passion for technological innovation.

The FinovateFall Startup Accelerator provides a perfect platform for budding business owners where they can pitch their innovative ideas to potential partners and investors. The event offers a blend of advanced financial technology, critical networking, and fun.

In addition, New York City beckons with a “never-sleeps” mix of off-hours entertainment options. Whether you’re a veteran New York enthusiast or a first-time visitor, Times Square’s vibrant lights, great shows, theatrical performances, and classic restaurants, ensure an unforgettable experience.

Register for the revolutionary FinovateFall 2023 NYC event now and get ready to be a part of a fintech event that you won’t want to miss.

To learn more, please visit https://ibn.fm/sLe8Y.